Quick Answer
Akebia Therapeutics, Inc. reported Net Income of -$5.34 million for fiscal year 2025.
Akebia Therapeutics, Inc. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$5.34M | +92.3% |
| 2024 | -$69.41M | -33.7% |
| 2023 | -$51.92M | +44.9% |
| 2022 | -$94.23M | +66.7% |
| 2021 | -$282.84M | +26.2% |
| 2020 | -$383.46M | -37.1% |
| 2019 | -$279.66M | -94.8% |
| 2018 | -$143.59M | -94.9% |
| 2017 | -$73.67M | +45.7% |
| 2016 | -$135.75M | -123.6% |
| 2015 | -$60.72M | -63.9% |
| 2014 | -$37.03M | -181.3% |
| 2013 | -$13.17M | -60.7% |
| 2012 | -$8.20M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $540.0K | +102.7% | +118.6% |
| June 30, 2025 | $247.0K | +102.9% | -96.0% |
| March 31, 2025 | $6.11M | +134.0% | +130.5% |
| September 30, 2024 | -$20.04M | -38.3% | -133.5% |
| June 30, 2024 | -$8.58M | +23.2% | +52.3% |
| March 31, 2024 | -$17.98M | +33.1% | -24.1% |
| September 30, 2023 | -$14.49M | +73.2% | -29.7% |
| June 30, 2023 | -$11.17M | -137.9% | +58.4% |
- Akebia Therapeutics, Inc. showed an increase of +92.3% in Net Income compared to the prior fiscal year.
- Over the 2012–2025 period, Akebia Therapeutics, Inc.’s net income has grown by 34.8% (from -$8.20 million to -$5.34 million).
- The most recent figure is from Akebia Therapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: